R

REGENXBIO

Develops AAV gene delivery therapies

Associate Director - Regulatory Affairs

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeRockville, MD, USA

About the Job

Requirements

  • A bachelor's degree is required.
  • Six to eight years of Regulatory Affairs experience, including product approval or launch experience, and deep knowledge of one or more therapeutic areas.
  • A track record of resolving complex global regulatory issues.
  • Hands-on experience preparing high-quality FDA and EMA submission documentation and Health Authority meeting materials.
  • Strong written and verbal communication skills and the ability to build trusted relationships with internal stakeholders, external partners, and health authorities.
  • The ability to work independently as well as collaboratively.
  • Proactive, creative problem-solving and strong decision-making skills.

Responsibilities

  • Set and drive global regulatory strategy from early Health Authority interactions through BLA/MAA registration.
  • Lead critical submission activities and regulatory writing, including pre-IND, orphan/paediatric investigation plan (PIP), Scientific Advice, End-of-Phase I/II, and pre-BLA/MAA meeting materials.
  • Serve as a strategic regulatory partner across development, commercialization, and lifecycle management for a therapeutic area.
  • Provide a forward-looking regulatory perspective on potential new products and work cross-functionally to develop innovative strategies.
  • Support commercial activities with regulatory guidance on labeling and promotional materials.
  • Provide regulatory insight and market interpretation to global development programs.
  • Work across R&D, Quality, Manufacturing, Supply Chain, Medical Affairs, Pharmacovigilance, and Regulatory Affairs to deliver high-quality dossiers and materials aligned with business priorities.
  • Partner with regional experts in the EU, Japan, and other markets to shape ex-US strategies and lead interactions with local regulatory agencies.
  • Represent REGENXBIO with industry teams, trade associations, and professional organizations.
  • Travel up to 15% as required.

Desired Qualifications

  • An advanced degree in biological sciences is preferred.
  • Experience in biologics, orphan diseases, or CNS development is preferred.

About the Company

REGENXBIO

Develops AAV gene delivery therapies

REGENXBIO focuses on gene therapy using its NAV Technology Platform, an adeno-associated virus (AAV) gene delivery system with exclusive rights to more than 100 AAV vectors. The company generates revenue by licensing its platform, collecting royalties, and engaging in collaborations, while also developing its own one-time gene therapies for retinal, rare, and neurodegenerative diseases. Key products in later-stage trials include ABBV-RGX-314 for wet AMD and diabetic retinopathy, RGX-202 for Duchenne muscular dystrophy, and RGX-121 for Hunter syndrome, with a goal to advance five new therapies to pivotal-stage or commercial status by 2025 and FDA review for RGX-121 targeted in early 2026. REGENXBIO differentiates itself by owning a broad AAV vector library and offering end-to-end capabilities—from research to manufacturing—alongside a diversified revenue model that includes royalties, collaborations, and milestones.

Company size
201-500
Company stage
IPO
Headquarters
Rockville, MD
Founded
2009

Recently Posted Jobs

Explore more opportunities at REGENXBIO

See more jobs